Replies to post #17 on TScan Therapeutics Inc (TCRX)

[jondoeuk]

Thanks. I agree. Last year, they identified over 110 novel solid tumour targets in samples from patients who responded to different types of immunotherapy, such as TIL. Taken together with them covering the most common HLAs, they could end up with the largest library of TCRs in the space.